New blood test could replace needle biopsies for breast cancer monitoring
NCT ID NCT04480814
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tested a new blood test (liquid biopsy) to find cancer DNA in 30 women with advanced ER+/HER2- breast cancer. The goal was to see if the test could detect cancer changes in blood as accurately as standard tissue biopsies. If successful, this could allow doctors to monitor cancer without repeated invasive procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aretaieio University Hospital of Athens
Athens, Attica, 11528, Greece
-
Metropolital Hospital
Piraeus, Piraeus, 18547, Greece
-
University General Hospital of Alexandroupoli
Alexandroupoli, Alexandroupolis, 68100, Greece
-
University General Hospital of Athens Attikon
Athens, Attica, 124 62, Greece
Conditions
Explore the condition pages connected to this study.